Quantitative estimation of the thermal dose-modifying factor for cis-diamminedichloroplatinum (CDDP) in tumour-bearing dogs

References

• Bull J. M. C., Baba H., Strebel F., Jenkins G., Alonso M., Siddik Z. H. Increased therapeutic gain of combined cisplatin and whole body hyperthermia by optimal heat/drug scheduling. Proceedings, 9th Annual North American Hyperthermia Group Meeting. 1989; 35
   Google Scholar
• Cox D. R., Snell E. J. Analysis of Binary Data, 23rd edn. Methuen, London 1989; 158–161
   Google Scholar
• Dahl O., Mella O. Hyperthermia and chemotherapeutic agents. An Introduction to the Practical Aspects of Clinical Hyperthermia, S. B. Field, J. W. Hand. Taylor & Francis, London 1990; 108–103
   Google Scholar
• Dewhirst M. W., Winget J. M., Edelstein-Keshet L., Sylvester J., Engler M., Thrall D. E., Page R. L., Oleson J. R. Clinical application of thermal iso effect dose. International Journal of Hyperthermia 1987; 3: 307–318
   PubMed Web of Science ®Google Scholar
• Douple E. V. Enhancement of cytotoxic effects of chemotherapeutic agents in vitro and in vivo. Hyperthermia and Oncology, Vol. 4: Hyperthermic Potentiation of Chemotherapeutic Agents, M. Urano, E. Douple, 1990, (in press)
   Google Scholar
• Engelhardt R. Hyperthermia and drugs. Recent Results in Cancer Research 1987; 104: 133–203
   Google Scholar
• Fisher G. A., Hahn G. M. Enhancement of cis-platinum(II) diaaminedichloride cytotoxicity by hyperthermia. National Cancer Institute Monograph 1982; 62: 255–257
   Google Scholar
• Herman T. S., Teicher B. A., Cathcart K. N. S., Kaufmann M. E., Lee J. B., Lee M. Effect of hyperthermia on cis-diamminedichloroplatinum(II) and Pt(Rh-123)2 in a human squamous cell line and a cis-diamminedichloroplatinum(II) resistant subline. Cancer Research 1988; 48: 51051–5105
   Web of Science ®Google Scholar
• Knapp D. W., Richardson R. C., DeNicola D. B., Long G. G., Blevins W. E. Cisplatin toxicity in the cat. Journal of veterinary Internal Medicine 1987; 1: 29–35
   PubMed Web of Science ®Google Scholar
• MacEwen E. G., Kurzman I. D., Rosenthal R. C., Smith B. W., Manley P. A., Roush J. K., Howard P. E. Therapy for osteosarcoma in dogs with intravenous injection of liposome-encapsulated muramyl tripeptide. Journal of the National Cancer Institute 1989; 81: 935–938
   PubMed Web of Science ®Google Scholar
• McChesney-Gillette S., Dewhirst M. W., Gillette E. L., Thrall D. E., Page R. L., Powers B. E., Withrow S. J., Rosner G., Wong C., Sim D. A. Response of canine soft tissue sarcomas to radiation or radiation plus hyperthermia: a randomized phase II study. International Journal of Hyperthermia 1992; 8: 309–320
   PubMed Web of Science ®Google Scholar
• Mella O., Eriksen R., Dahl O., Laerum O. D. Acute systemic toxicity of combined cis-diamminedichloroplatinum and hyperthermia in the rat. European Journal of Cancer and Clinical Oncology 1987; 23: 365–373
   PubMedGoogle Scholar
• O'Quigley J., Pepe M., Fisher L. Continual reassessment method: a practical design for phase I clinical trials in cancer. Biometrics 1990; 46: 33–48
   PubMed Web of Science ®Google Scholar
• Page R. L., Macy D. W., Ogilvie G. K., Rosner G. L., Dewhirst M. W., Thrall D. E., Withrow S. J., McEntee M. C., Cline J. M., Heidner G. L., Novotney C. A., Gillette E. L. Phase III evaluation of doxorubicin and whole-body hyperthermia in dogs with lymphoma. International Journal of Hyperthermia 1992; 8: 187–198
   PubMed Web of Science ®Google Scholar
• Riviere J. E., Page R. L., Rogers R. A., Chang S. K., Dewhirst M. W., Thrall D. E. Nonuniform alteration of cis-diamminedichloroplatinum(II) tissue distribution in dogs with whole body hyperthermia. Cancer Research 1990; 50: 1075–1080
   PubMed Web of Science ®Google Scholar
• Roshchin A. V., Veselov V. G., Panova A. I. Industrial toxicology of metals of the platinum group. Journal of Hygiene, Epidemiology, Microbiology, and Immunology 1984; 28: 17–24
   PubMedGoogle Scholar
• Storer B. E. Design and analysis of phase I clinical trials. Biometrics 1989; 45: 925–937
   PubMed Web of Science ®Google Scholar
• Storer B. E., DeMets D. Current phase I/II designs: are they adequate. Journal of Clinical Research and Drug Development 1987; 1: 121–130
   Google Scholar
• Strebel F., Baba H., Stephens L. C., Bull J. M. C. Protective effect of altered heat/drug schedule on whole body hyperthermia+cisplatin-mediated late renal toxicity in rats. Proceedings, 10th Annual North American Hyperthermia Group Annual Meeting. 1990; 23
   Google Scholar
• Thrall D. E., Dewhirst M. W., Page R. L., Samulski T. V., McLeod D. A., Oleson J. R. A comparison of temperatures in canine solid tumours during local and whole-body hyperthermia administered alone and simultaneously. International Journal of Hyperthermia 1990; 6: 305–317
   PubMed Web of Science ®Google Scholar
• Thrall D. E., Page R. L., Dewhirst M. W., Meyer R. E., Hoopes P. J., Kornegay J. N. Temperature measurements in normal and tumor tissue in dogs undergoing whole body hyperthermia. Cancer Research 1986; 46: 6229–6235
   PubMed Web of Science ®Google Scholar
• Urano M., Kahn J., Kenton L. A. The effect of cis-diamminedichloroplatinum(II) treatment at elevated temperatures on murine fibrosarcoma, FSa-II. Internarional Journal of Hyperthermia 1990; 6: 563–570
   PubMed Web of Science ®Google Scholar
• Wallner K. E., DeGregorio M. W., Li G. C. Hyperthermic potentiation of cis-diamminedichloroplatinum(II) cytotoxicity in Chinese hamster ovary cells resistant to the drug. Cancer Research 1986; 46: 6242–6245
   PubMed Web of Science ®Google Scholar
• Wondergem J., Bulger R. E., Strebel F. R., Newman R. A., Travis E. L., Stephens L. C., Bull J. M. C. Effect of cis-diamminedichloroplatinum(II) combined with whole body hyperthermia on renal injury. Cancer Research 1988; 48: 440–446
   PubMed Web of Science ®Google Scholar